AWP
NVS icon

Ascent Wealth Partners’s Novartis NVS Stock Holding History

Ascent Wealth Partners’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.58M Buy
16,473
+575
+4% +$86.2K 0.26% 77
2026
Q1 		$2.43M Buy
15,898
+242
+2% +$37.1K 0.28% 80
2025
Q4 		$2.16M Buy
15,656
+19
+0.1% +$2.49K 0.25% 80
2025
Q3 		$2.01M Sell
15,637
-368
-2% -$44.9K 0.23% 87
2025
Q2 		$1.94M Sell
16,005
-136
-0.8% -$15.3K 0.24% 85
2025
Q1 		$1.8M Sell
16,141
-62
-0.4% -$6.6K 0.24% 88
2024
Q4 		$1.58M Buy
16,203
+169
+1% +$18K 0.21% 87
2024
Q3 		$1.84M Sell
16,034
-53
-0.3% -$6.01K 0.26% 82
2024
Q2 		$1.71M Sell
16,087
-123
-0.8% -$12.3K 0.25% 85
2024
Q1 		$1.57M Buy
16,210
+239
+1% +$24.5K 0.23% 83
2023
Q4 		$1.61M Buy
15,971
+157
+1% +$15.2K 0.26% 73
2023
Q3 		$1.61M Buy
15,814
+1,080
+7% +$110K 0.3% 67
2023
Q2 		$1.49M Buy
14,734
+867
+6% +$86.7K 0.26% 79
2023
Q1 		$1.28M Buy
13,867
+540
+4% +$47.2K 0.26% 85
2022
Q4 		$1.21M Buy
13,327
+1,201
+10% +$101K 0.26% 86
2022
Q3 		$922K Sell
12,126
-90
-0.7% -$7.46K 0.22% 89
2022
Q2 		$1.04M Buy
12,216
+2,888
+31% +$253K 0.24% 85
2022
Q1 		$818K Buy
9,328
+1,397
+18% +$121K 0.15% 93
2021
Q4 		$693K Buy
7,931
+184
+2% +$15.3K 0.12% 101
2021
Q3 		$634K Buy
7,747
+1,955
+34% +$176K 0.12% 109
2021
Q2 		$528K Buy
+5,792
New +$516K 0.1% 108

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Ascent Wealth Partners's NVS Position: Q2 2026 in Review

Ascent Wealth Partners increased its Novartis (NVS) stake by 3.6% in Q2 2026, buying an estimated $86.2K and bringing the position to 16,473 shares worth $2.58M. The position accounts for 0.26% of the portfolio, ranked #77.

Ascent Wealth Partners first reported a position in NVS in Q2 2021 and has held it in 21 quarters since. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Ascent Wealth Partners held 16,473 shares of Novartis worth $2.58M as of Q2 2026.
  • Ascent Wealth Partners bought 575 Novartis shares in Q2 2026, an estimated $86.2K.
  • Novartis made up 0.26% of Ascent Wealth Partners's portfolio in Q2 2026, its #77 holding.
  • Ascent Wealth Partners first reported a position in Novartis in Q2 2021 and has held it in 21 quarters since.
  • 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Ascent Wealth Partners's 13F filing for Q2 2026, filed 31 Jul 2026.